CNN on MSN11 天
Novo Nordisk’s next-generation weight-loss drug matches Lilly’s Zepbound in major trial ...
The experimental drug puts semaglutide, the ingredient in Ozempic and the weight-loss drug Wegovy, together with a medicine ...
What the results of Wegovy’s longest clinical trial yet show about weight loss, side ...
A previous clinical trial showed even greater average weight loss for Wegovy: about 15% on average over 68 weeks, compared ...
USA Today27 天
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in the first large, head-to-head trial of the highly in ...
Yahoo26 天
Wegovy and Zepbound are leading this year's weight loss drug prescription surge
The weight loss revolution is in full swing, with the number of patients receiving Wegovy (NVO) having doubled while those receiving Zepbound have tripled since January 2024. While demand is ...
Bloomberg L.P.27 天
Lilly’s Zepbound Beats Novo’s Wegovy in Head-to-Head Trial
Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters. In a study sponsored by Lilly ...